Mı́riam Tendler - Concepedia

Author

Mı́riam Tendler

Also Known As

M J TENDLER, M Tendler, M. Tendler, Miriam Tendler, Míriam Tendler, Míriam Tendler, Mı́riam Tendler, Tendler, Miriam, Tendler,Miriam

Publications

1.4K

Citations

H-Index

Concepts

All Affiliations

Fundação Oswaldo Cruz Instituto Butantan Universidade de São Paulo Fundação Ataulpho de Paiva Instituto Evandro Chagas

About

Mı́riam Tendler is an author at Fundação Oswaldo Cruz specializing in medicine, immunology, and vaccination.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	16	20	990
2	Allergy	6	6	309
3	Natural Sciences	2	2	207
4	Biochemistry	2	2	207
5	Education	1	1	30

Mı́riam Tendler

Publications

1.1K

Citations

H-Index

Page 1

	Year	Citations
A Schistosoma mansoni fatty acid-binding protein, Sm14, is the potential basis of a dual-purpose anti-helminth vaccine. Mı́riam Tendler, Cristiana Alves Brito, Mônica Magno Vilar, Proceedings of the National Academy of Sciences Schistosoma MansoniParasitic DiseaseImmunologyImmunotherapeuticsInnate Immunity	1996	231
A 14-kDa Schistosoma mansoni polypeptide is homologous to a gene family of fatty acid binding proteins Doris Moser, Mı́riam Tendler, Gillian M. Griffiths, Journal of Biological Chemistry Protein FunctionProtein ExpressionBiochemistryFatty AcidsMedicine	1991	169
Schistosomiasis vaccine candidate Sm14/GLA-SE: Phase 1 safety and immunogenicity clinical trial in healthy, male adults Marília Santini-Oliveira, Rhea N. Coler, Jucara F. C. Parra, Vaccine VaccinationVaccine SafetyVaccine DevelopmentMedicineImmunodeficiencies	2015	114
Schistosoma mansoni: Vaccination with adult worm antigens Mı́riam Tendler, Roberto Magalhães Pinto, A. Oliveira Lima, International Journal for Parasitology VaccinationSchistosoma MansoniParasitic DiseaseImmunologySchistosomiasis	1986	73
Recombinant<i>Mycobacterium bovis</i>BCG Expressing the Sm14 Antigen of<i>Schistosoma mansoni</i>Protects Mice from Cercarial Challenge Paula B. Varaldo, Luciana C. C. Leite, Waldely O. Dias, Infection and Immunity Schistosoma MansoniMicrobial PathogensImmunodeficienciesInnate Immune SystemImmunology	2004	54
Vaccination against <i>Fasciola hepatica</i> infection using a <i>Schistosoma mansoni</i> defined recombinant antigen, Sm14 Marília Sirianni dos Santos Almeida, Humberto Torloni, Paulo Lee‐Ho, Parasite Immunology	2003	50
An experimental bivalent peptide vaccine against schistosomiasis and fascioliasis Mônica Magno Vilar, Frank Barrientos, Marília Sirianni dos Santos Almeida, Vaccine VaccinationSchistosomiasisVaccine DesignInfection ControlMedicine	2003	45
Gene Structure and M20T Polymorphism of theSchistosoma mansoni Sm14 Fatty Acid-binding Protein Celso Raul Romero Ramos, Rita C. R. Figueredo, Thelma A. Pertinhez, Journal of Biological Chemistry	2003	39
Stability improvement of the fatty acid binding protein Sm14 from S. mansoni by Cys replacement: Structural and functional characterization of a vaccine candidate Celso R. Ramos, Alberto Spisni, Sérgio Oyama, Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics Proteinlipid InteractionProtein FunctionBiochemistryNatural SciencesProtein Sm14	2008	38
r-Sm14 - pRSETA efficacy in experimental animals Celso Raul Romero Ramos, Mônica Magno Vilar, Ana L. T. O. Nascimento, Memórias do Instituto Oswaldo Cruz Schistosoma MansoniMicrobial PathogensImmunologyEscherichia ColiImmunotherapeutics	2001	35

Page 1